A paper that priced it
Published 1 October 2026
A consultation paper is not supposed to matter. It is not law, not regulation, not even a draft rule - it is a request for comments, the regulatory equivalent of thinking out loud. Yet the paper IRDAI published on 23 September 2026 erased Rs.37,000 crore of market value in four sessions, cut a brokerage's target on India's largest insurance distributor by 53%, and turned a three-month-old IPO into a cautionary tale. This chapter is the anatomy of that paper - what it actually proposes, why the machine's reaction was so violent, and what happens between now and the day the comments close.
The paper's core is a set of numbers with glide paths attached. For life insurance, first-year commissions would be capped at 20% of premium for distributors and 25% for agents - less than half today's levels - and total expenses of management would be walked down to 15% of premium in two years and 12.5% in five. For general insurance, the expense ceiling falls to 25% in two years and 20% in five, with health, motor and term commissions cut by as much as half to two-thirds, according to market reports on the paper's annexures. Around the caps sits the conduct machinery the machine fears more than the caps themselves: commission claw-back when mis-selling is proven, public disclosure of dark patterns, public disclosure of distributor conduct, and identification of the individuals involved in unfair practices. The paper does not merely propose to cut the fuel. It proposes to print the names of the people pumping it.
The market's verdict arrived in four sessions and one research note. PB Fintech fell 42% and lost Rs.37,000 crore of market value, hitting a 52-week low at Rs.1,057.80 by the fifth session, down 44% in five days. Turtlemint, listed barely three months earlier at an 11% discount to its own IPO price, fell 20% twice. And Bernstein - which days earlier had seen a 91% upside in PB Fintech - cut its price target 53%, from Rs.2,310 to Rs.1,085, and gave the company eighteen "do-or-die" months to reinvent its economics. The note's logic, in essence: if the toll is halved, the toll booth is worth half, and only a radical change of business saves the rest.
The paper backs its caps with forensic accounting, and the channel data is the part the industry cannot talk away. Across the corporate-agency channel - the banks and finance companies that move the bulk of life policies - new-business premium grew 28% between FY23 and FY25 while distributor remuneration grew 125%; the payout now consumes nearly 27% of the first-year premium before a rupee reaches any fund. The broker channel is starker still: premium up 37%, commissions up 173%, average rates doubling from 8.5% to 17% in two years, motor commissions nearly tripling from 9% to 25%, retail health from 10% to 30%. Retail customers supplied 54% of the premium brokers placed and paid 78% of the commissions - the skew of who funds the machine, in one line.
The three ways this ends
Between the paper and the rulebook stands the consultation window - comments close 25 October 2026 - and three paths out of it. The first: the paper becomes regulation broadly as drafted. The distribution economics of an entire industry are rebuilt; commissions fall by half; the weakest distributors fold; premiums for savings products reprice; and the Rs.60,800 crore persuasion budget is spent on something else or returned to policyholders as value. The second path is the Indian tradition: the industry lobbies, the caps soften in the final rules, the glide paths stretch, and the machine adapts - as it did after the 2010 ULIP reset, when the product was renamed, re-capped and resold within a few years. The third path is the quiet one: the paper joins the archive of well-documented intentions, and the 3.7% penetration figure files another annual report.
Which path is likeliest? The honest answer is that the regulator has never before put this much of its own credibility on the table. The paper indicts the 2023 deregulation - its own decision - by name and number; it publishes the remuneration multiples; it uses the word mis-selling as a structural diagnosis, not an anecdote. Regulators do not write documents like that to retreat from them completely. But the machine has survived every reform ever aimed at it by converting each one into a product feature, and the industry's consultation responses will argue, with straight faces and some truth, that commission caps shrink distribution, slow penetration, and hurt the same underinsured country the caps are meant to protect. The control experiment for that argument ran in Britain after 2012: the sellers thinned out, the honest products survived, and the mis-selling economics died. India gets to choose its version of that ending starting 25 October. The market has already voted on what the choice is worth.
The industry's answer, and the brokerages'
The machine did not take the paper silently. Within days, the industry's proxies were briefing the same argument in every financial newsroom: commission caps will shrink distribution, agents will exit, penetration will suffer, and the underinsured country will pay for the regulator's consumer protection. The argument has the machine's usual structure - a true premise (distribution costs money) holding up a false conclusion (therefore this distribution, at this price, is necessary). The brokerages translated it into numbers without the sentimentality. The Economic Times' summary of the downgrade cycle records that Bernstein, Jefferies and Morgan Stanley all flagged pressure on earnings, distribution economics and valuations, with specific risks to the health-insurance book and the POSP sales network - the analyst corps stating, in the passive voice of their profession, that the listed sector's profits are a function of the payout rates the paper proposes to cut. Nobody on the sell side claimed the caps were wrong. They claimed the caps were expensive. Both can be true; that is the whole point.
Buried at number eighteen on the question list is the idea the machine fears most, phrased with a regulator's politeness: is the sector ready to move from opaque commissions paid by insurers - unknown to the policyholder - to a fee the policyholder pays the distributor directly? Every other proposal trims the toll. That one abolishes the toll booth, because an agent paid by the buyer works for the buyer, and the whole architecture of the first-premium harvest - the conventions, the clubs, the laundered service contracts - exists only because the payer and the buyer are different people. It is a consultation question, not a draft rule, and it may well die in the comment pile. But it is on the record now, numbered, with a submission portal attached.
The paper itself anticipates the lobbying, in its own quiet way. Its framing invokes the national goal of "insurance for all by 2047" under Viksit Bharat, and asks the respondents - insurers, distributors, agents, the public - to answer specific numbered questions about the glide paths, the claw-backs, the disclosure rules. That structure matters. A regulator that asks thirty-two numbered questions is building a record: every industry response will be on file, attributable, and answerable against the paper's own published data. The machine can still win - it has won every previous round by attrition - but it will have to win in writing, arguing that a third of the first premium is the fair price of persuasion, against a regulator that has already published the receipts.